Cero Terapeutics Hldg Inc (CERO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2002 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -490 | -378 | N/A | -1 | -2,380 |
| Depreciation Amortization | N/A | N/A | N/A | N/A | 350 |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | 1 | N/A |
| Other Working Capital | 237 | 97 | N/A | 1 | -1,310 |
| Other Operating Activity | -292 | -27 | 0 | -1 | -220 |
| Operating Cash Flow | $-545 | $-308 | $N/A | $N/A | $-3,560 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | N/A | -160 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -10 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $-170 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | 0 | 0 | 0 | 3 |
| Financing Cash Flow | $N/A | $N/A | $N/A | $N/A | $3 |
| Beginning Cash Position | 1,099 | 1,099 | N/A | N/A | 4,140 |
| End Cash Position | 554 | 791 | N/A | N/A | 400 |
| Net Cash Flow | $-545 | $-308 | $N/A | $N/A | $-3,740 |
| Free Cash Flow | |||||
| Operating Cash Flow | -545 | -308 | N/A | N/A | -3,560 |
| Free Cash Flow | -545 | -308 | 0 | 0 | -3,560 |